Related Experiment Videos
Immunophenotyping of leukemias using a cluster of differentiation antibody microarray
L Belov1, O de la Vega, C G dos Remedios
1Department of Biochemistry, Institute for Biomedical Research, University of Sydney, NSW 2006, Australia.
Cancer Research
|June 5, 2001
Summary
A new microarray technique allows for the simultaneous detection of over 50 cluster of differentiation (CD) antigens on leukemia cells, improving immunophenotyping accuracy. This method aids in distinguishing leukemia types from normal cells and offers a faster, more comprehensive diagnostic tool.
Area of Science:
- Hematology
- Immunology
- Biotechnology
Background:
- Leukemias are diagnosed using morphology, immunophenotype, cytochemistry, and karyotype.
- Current flow cytometry methods for immunophenotyping are limited to analyzing approximately three cluster of differentiation (CD) antigens per assay.
- Accurate identification of CD antigen expression on leukemia cells is crucial for diagnosis and understanding disease mechanisms.
Purpose of the Study:
- To develop a rapid, simple procedure for concurrent determination of over 50 CD antigens on leukocytes or leukemia cells.
- To establish a novel microarray-based immunophenotyping method for leukemia diagnosis.
- To compare the diagnostic utility of the microarray technique with existing methods like flow cytometry.
Main Methods:
- Development of a microarray of antibodies for simultaneous detection of multiple CD antigens.
- Application of cell suspensions to the antibody microarray, allowing cells to bind to corresponding CD antigen dots.
- Analysis of dot patterns to represent the immunophenotype of leukocytes and leukemia cells.
Main Results:
- Distinct and reproducible dot patterns were obtained for various leukemias, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia, and T-cell acute lymphoblastic leukemia.
- The microarray successfully identified key CD antigens differentiating CLL from normal peripheral blood leukocytes, such as CD19, CD20, CD21, CD22, CD23, CD24, CD25, and CD37.
- Results from the microarray analysis of 48 CD antigens showed good agreement with conventional flow cytometry.
Conclusions:
- The developed antibody microarray enables extensive immunophenotyping, offering a significant advancement over traditional methods.
- This technique provides a rapid and comprehensive approach for identifying leukemia subtypes based on CD antigen expression.
- The microarray platform facilitates enhanced diagnostic capabilities for leukemias and lymphomas.